Agarwal R et al. |
A randomized trial of intravenous and oral iron in chronic kidney disease. |
2015 |
Kidney Int. |
pmid:26083656
|
Connor JR et al. |
Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations. |
2015 |
PLoS ONE |
pmid:25973894
|
Bhandari S et al. |
A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients. |
2015 |
Nephrol. Dial. Transplant. |
pmid:25925701
|
Toblli JE et al. |
Cardiovascular outcomes of intravenous iron in perspective of clinical trials and the use of different iron preparations. |
2015 |
Int. J. Cardiol. |
pmid:25838213
|
Dai P et al. |
Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids. |
2015 |
AAPS J |
pmid:25762448
|
Toblli JE et al. |
Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron. |
2015 |
Heart Lung Circ |
pmid:25666998
|
Shiue E et al. |
Improving product yields on D-glucose in Escherichia coli via knockout of pgi and zwf and feeding of supplemental carbon sources. |
2015 |
Biotechnol. Bioeng. |
pmid:25258165
|
Tiwari P et al. |
Preventive effects of butyric acid, nicotinamide, calcium glucarate alone or in combination during the 7, 12-dimethylbenz (a) anthracene induced mouse skin tumorigenesis via modulation of K-Ras-PI3K-AKTpathway and associated micro RNAs. |
2016 |
Biochimie |
pmid:26655363
|
Barbieri C et al. |
Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients. |
2016 |
PLoS ONE |
pmid:26939055
|
Bitsi S et al. |
Profound hyperglycemia in knockout mutant mice identifies novel function for POU4F2/Brn-3b in regulating metabolic processes. |
2016 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:26670484
|